Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Amgen is 'Buy'. Macroaxis provides Amgen buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Amgen positions. The advice algorithm takes into account all of Amgen available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Amgen buy-and-hold prospective. Check also Amgen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus.
Amgen Current RecommendationFor the selected time horizon Amgen has a risk adjusted performance of 0.01, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.2636 and treynor ratio of 0.0Macroaxis provides buy, hold, or sell suggestion on Amgen to complement and cross-verify current analyst consensus on Amgen. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Amgen is not overpriced, please confirm all Amgen fundamentals including its EBITDA, Cash Flow from Operations and the relationship between Price to Book and Total Debt . Given that Amgen has Price to Earning of 61.01 times, we suggest you validate Amgen market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
Amgen Thematic Classifications
Returns Distribution Density
Amgen Volatility Alert
|Better Than Average||Worse Than Average||Compare Amgen to competition|